CHRISTINA MCENERY: Open Payments
NPI 1346779022 · ELMHURST, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 32 payments from 18 companies in 2025. Trend: 2023 $467 · 2024 $361 · 2025 $817
Food & beverage: $787Speaker / faculty: $30
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $121 |
| Merck Sharp & Dohme LLC | 4 | $96 |
| Janssen Biotech, Inc. | 3 | $81 |
| JAZZ PHARMACEUTICALS INC. | 2 | $73 |
| Genentech USA, Inc. | 2 | $59 |
| Lilly USA, LLC | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $51 |
| Gilead Sciences, Inc. | 2 | $43 |
| Becton, Dickinson and Company | 1 | $30 |
| SHORLA ONCOLOGY INC. | 1 | $29 |
Products named: KEYTRUDA, PLUVICTO, Trodelvy, ZIIHERA, ZEPZELCA, TECVAYLI, Tecentriq, IMKELDI.
Industry payments across IL — which companies pay providers there.
